在明显控制良好的中持续的精神症状:病例报告
Masahiro Hata1, Rei Sakagami1, Shun Takahashi1,2,3,4
1Department of Psychiatry, Osaka University Graduate School of Medicine, Osaka, Japan.
BJPsych open
|September 15, 2025
概括
患者的持续性精神症状可能源于潜在的发作,而不仅仅是情绪障碍. 优化抗发作药物可以解决这些症状并改善功能.
科学领域:
- 神经学 神经学
- 精神病学是一个精神病学.
背景情况:
- 经常伴有精神病症状,如抑郁和易怒.
- 间隔性失调障碍 (IDD) 是一种常见的诊断,通常通过精神病学干预来治疗.
- 尽管接受了治疗,但症状持续存在,可能表明存在潜在的性发作原因.
研究的目的:
- 为了强调和持续的精神症状之间的联系.
- 突出突发性活动在精神疾病表现中的作用.
- 倡导在抗治疗精神病例中考虑.
主要方法:
- 一个40多岁的妇女的病例报告,患有和持续的精神症状.
- 临床特征,精神病治疗和神经学评估的详细描述.
- 在药物调整后对治疗结果的评估.
主要成果:
- 最初被诊断为IDD的患者,对精神病药物 (埃斯基塔洛普拉姆,奥兰扎平) 呈现部分反应.
- 进一步的调查揭示了叶发症的症状.
- 调整抗发作疗法 (lacosamide) 导致精神症状完全消失和功能恢复.
结论:
- 在得到良好控制的中持续存在的精神症状可能表明发病的机制.
- 优化抗发作药物对精神病和功能改善至关重要.
- 多学科评估对于准确的诊断和有效的管理至关重要.
相关概念视频
Epilepsy and Seizures: Overview
1.2K
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
1.2K
Seizures: Classification
1.4K
Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
1.4K
Psychosis: Goals of Pharmacotherapy
476
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
476
Electroconvulsive Therapy
916
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
916
Mania and Antimanic Drugs: Overview
561
Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as...
561
Antiepileptic Drugs: Potassium Channel Activators
635
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
635


